posted on 2021-10-01, 11:36authored byAbel Jarell, Basil Skenderis, Larry D Dillon, Kelsey Dillon, Brian Martin, Ann P Quick, Jennifer J Siegel, Briana B Rackley, Robert W Cook
Supplementary Figure 2. The 31-gene expression profile stratifies recurrence and metastasis risk in patients with cutaneous melanoma
31-GEP subclass and main class analysis in stage I-III melanoma. The 31-GEP significantly stratified patient risk of recurrence (left, P<0.001), distant metastasis (middle, P<0.001), and melanoma-specific death (right, P<0.001).